4//SEC Filing
Eleven Biotherapeutics, Inc. 4
Accession 0001205535-15-000005
$CARMCIK 0001485003operating
Filed
Aug 13, 8:00 PM ET
Accepted
Aug 14, 4:20 PM ET
Size
7.1 KB
Accession
0001205535-15-000005
Insider Transaction Report
Form 4
MCCABE JOHN J
Senior Vice President, Finance
Transactions
- Award
Common Stock
2015-08-12+10,000→ 10,000 total - Award
Stock Option (Right to Buy)
2015-08-12+20,000→ 20,000 totalExercise: $4.09Exp: 2025-08-11→ Common Stock (20,000 underlying)
Footnotes (2)
- [F1]Represents restricted stock units which vest as to 33.33% of the original number of restricted stock units granted to Mr. McCabe on each of the six-month, twelve-month and eighteen-month anniversaries of the grant date.
- [F2]This option was granted on August 12, 2015 and vests over four years, with 6.25% of the shares underlying the option vesting at the end of each successive three-month period after August 1, 2015 until August 1, 2019.
Documents
Issuer
Eleven Biotherapeutics, Inc.
CIK 0001485003
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001485003
Filing Metadata
- Form type
- 4
- Filed
- Aug 13, 8:00 PM ET
- Accepted
- Aug 14, 4:20 PM ET
- Size
- 7.1 KB